ISIN | LU1819586188 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Sustainable Healthcare I2 |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) |
Bank am Bellevue AG Küsnacht Phone: +41 44 267 67 67 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare sector taking account of sustainability criteria. The fund can also invest in companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of “healthcare sector”, the healthcare sector includes companies from the areas of pharmaceuticals, medical technology, biotechnology and related sectors. |
Peculiarities |
Current Price * | 187.04 EUR | 05.09.2024 |
---|---|---|
Previous Price * | 189.26 EUR | 04.09.2024 |
52 Week High * | 192.01 EUR | 30.08.2024 |
52 Week Low * | 164.15 EUR | 27.10.2023 |
NAV * | 187.04 EUR | 05.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 114,442,534 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | +9.21% |
29.12.2023 - 05.09.2024
29.12.2023 05.09.2024 |
---|---|---|
YTD Performance (in CHF) | +10.36% |
29.12.2023 - 05.09.2024
29.12.2023 05.09.2024 |
1 month | +7.05% |
05.08.2024 - 05.09.2024
05.08.2024 05.09.2024 |
3 months | +5.02% |
05.06.2024 - 05.09.2024
05.06.2024 05.09.2024 |
6 months | +7.12% |
05.03.2024 - 05.09.2024
05.03.2024 05.09.2024 |
1 year | +7.40% |
05.09.2023 - 05.09.2024
05.09.2023 05.09.2024 |
2 years | +2.21% |
06.09.2022 - 05.09.2024
06.09.2022 05.09.2024 |
3 years | -7.59% |
07.09.2021 - 05.09.2024
07.09.2021 05.09.2024 |
5 years | -2.37% |
15.06.2021 - 05.09.2024
15.06.2021 05.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Vertex Pharmaceuticals Inc | 3.42% | |
---|---|---|
Regeneron Pharmaceuticals Inc | 3.31% | |
Intuitive Surgical Inc | 3.25% | |
Insulet Corp | 3.17% | |
Eli Lilly and Co | 3.09% | |
IQVIA Holdings Inc | 2.93% | |
UCB SA | 2.81% | |
Biomarin Pharmaceutical Inc | 2.78% | |
Boston Scientific Corp | 2.76% | |
Alcon Inc | 2.74% | |
Last data update | 31.07.2024 |
TER | 1.40% |
---|---|
TER date | 29.01.2021 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | 1.35% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |